LRRK2 and Parkinson disease: For PD, neuron-derived BEV α-synuclein seed amplification detected misfolded protein up to a decade pre-diagnosis, and sEV phospho-Rab12Ser106 in LRRK2-G2019S carriers reflected response to LRRK2 inhibitor therapy [83,129].